Computational Approaches for Predicting Drug Interactions with Human Organic Anion Transporter 4 (OAT4)
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.4c00984 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Lucy Martinez-Guerrero und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, 1703 E. Mabel, Tucson, Arizona 85721, United States. Hauptthemen laut MEDLINE: Organic Anion Transporters, Sodium-Independent. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Human Organic Anion Transporter 4 (OAT4) is predominantly expressed in the kidneys, particularly in the apical membrane of the proximal tubule cells. This transporter is involved in the renal handling of endogenous and exogenous organic anions (OAs), making it an important transporter for drug-drug interactions (DDIs). To better understand OAT4-compound interactions, we generated single concentration (25 μM) in vitro inhibition data for over 1400 small molecules against the uptake of the fluorescent OA 6-carboxyfluorescein (6-CF) in Chinese hamster ovary (CHO) cells. Several drugs exhibiting higher than 50% inhibition in this initial screen were selected to determine IC50 values against three structurally distinct OAT4 substrates: estrone sulfate (ES), ochratoxin A (OTA), and 6-CF. These IC50 values were then compared to the drug plasma concentration as per the 2020 FDA drug-drug interaction (DDI) guidance. Several screened compounds, including some not previously reported, emerged as novel inhibitors of OAT4. These data were also used to build machine learning classification models to predict the activity of potential OAT4 inhibitors. We compared multiple machine learning algorithms and data cleaning techniques to model these screening data and investigated the utility of conformal predictors to predict OAT4 inhibition of a leave-out set. These experimental and computational approaches allowed us to model diverse and unbalanced data to enable predictions for DDIs mediated by this transporter.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, 1703 E. Mabel, Tucson, Arizona 85721, United States.
- Collaborations Pharmaceuticals, Inc., 840 Main Campus Dr., Raleigh, North Carolina 27606, United States.
- Department of Physiology, College of Medicine, University of Arizona, 1200 E. University Blvd., Tucson, Arizona 85724, United States.
ORCID-Profile: Lucy Martinez-Guerrero, Patricia A Vignaux, Thomas R Lane, Sean Ekins
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
Zitieren
APA
Martinez-Guerrero, L., Vignaux, P. A., Harris, J. S., Lane, T. R., Urbina, F., Wright, S. H., Ekins, S., & Cherrington, N. J. (2025). Computational Approaches for Predicting Drug Interactions with Human Organic Anion Transporter 4 (OAT4). Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00984
Vancouver
Martinez-Guerrero L, Vignaux PA, Harris JS, Lane TR, Urbina F, Wright SH, et al. Computational Approaches for Predicting Drug Interactions with Human Organic Anion Transporter 4 (OAT4). Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.4c00984
BibTeX
@article{MartinezGuerrero2025,
author = {Martinez-Guerrero, Lucy and Vignaux, Patricia A and Harris, Joshua S and Lane, Thomas R and Urbina, Fabio and Wright, Stephen H and Ekins, Sean and Cherrington, Nathan J},
title = {Computational Approaches for Predicting Drug Interactions with Human Organic Anion Transporter 4 (OAT4)},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.4c00984}
}
EUVIMED